|
| Immunogenic cell death inducers as anticancer agents |
|
https://doi.org/10.18632/oncotarget.2266
Oliver Kepp, Laura Senovilla, and Guido Kroemer
|
| 5190-5191 |
|
| Targeting lemurs against cancer metastasis |
|
https://doi.org/10.18632/oncotarget.2271
Yichen Xu, Hua Zhang, and Georgios Giamas
|
| 5192-5193 |
|
| Ras in epidermal proliferation |
|
https://doi.org/10.18632/oncotarget.2275
Matthias Drosten, Carmen G. Lechuga, and Mariano Barbacid
|
| 5194-5195 |
|
| Knowledgebased computational models |
|
https://doi.org/10.18632/oncotarget.2276
Wim Verhaegh, and Anja van de Stolpe
|
| 5196-5197 |
|
| Structural basis of nSH2 regulation and lipid binding in PI3Kα |
|
https://doi.org/10.18632/oncotarget.2263
Michelle S. Miller, Oleg Schmidt-Kittler, David M. Bolduc, Evan T. Brower, Daniele Chaves-Moreira, Marc Allaire, Kenneth W. Kinzler, Ian G. Jennings, Philip E. Thompson, Philip A. Cole, L. Mario Amzel, Bert Vogelstein, and Sandra B. Gabelli
|
| 5198-5208 |
|
| NYESO1 as a potential immunotherapeutic target in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2101
Eva Giesen, Lucia B. Jilaveanu, Fabio Parisi, Yuval Kluger, Robert L. Camp, and Harriet M. Kluger
|
| 5209-5217 |
|
| An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma LGPUCC and its potential use for surveillance after transurethral resection using urine |
|
https://doi.org/10.18632/oncotarget.2129
Leonel Maldonado, Mariana Brait, Christina Michailidi, Enrico Munari, Tina Driscoll, Luciana Schultz, Trinity Bivalacqua, Mark Schoenberg, David Sidransky, George J. Netto, and Mohammad Obaidul Hoque
|
| 5218-5233 |
|
| Low PKCα expression within the MRDHR stratum defines a new subgroup of childhood TALL with very poor outcome |
|
https://doi.org/10.18632/oncotarget.2062
Gloria Milani, Paola Rebora, Benedetta Accordi, Luisa Galla, Silvia Bresolin, Gianni Cazzaniga, Barbara Buldini, Rossella Mura, Saverio Ladogana, Eugenia Giraldi, Valentino Conter, Geertruy Te Kronnie, Maria Grazia Valsecchi, and Giuseppe Basso
|
| 5234-5245 |
|
| High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients |
|
https://doi.org/10.18632/oncotarget.2124
Israel Cañadas, Ãlvaro Taus, Iria González, Xavier Villanueva, Javier Gimeno, Lara Pijuan, Manuel Dómine, Albert Sánchez-Font, Ivan Vollmer, Silvia Menéndez, Oriol ArpÃ, Sergi Mojal, Federico Rojo, Ana Rovira, Joan Albanell, and Edurne Arriola
|
| 5246-5256 |
|
| LASP1 is a novel BCRABL substrate and a phosphorylationdependent binding partner of CRKL in chronic myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.2072
Jochen J. Frietsch, Carolin Kastner, Thomas G. P. Grunewald, Hardy Schweigel, Peter Nollau, Janine Ziermann, Joachim H. Clement, Paul La Rosée, Andreas Hochhaus, and Elke Butt
|
| 5257-5271 |
|
| CD271 is an imperfect marker for melanoma initiating cells |
|
https://doi.org/10.18632/oncotarget.1967
Yann Cheli, Vanessa F. Bonnazi, Arnaud Jacquel, Maryline Allegra, Gian Marco De Donatis, Philippe Bahadoran, Corine Bertolotto, and Robert Ballotti
|
| 5272-5283 |
|
| Circulating miR148b and miR133a as biomarkers for breast cancer detection |
|
https://doi.org/10.18632/oncotarget.2014
Jie Shen, Qiang Hu, Michael Schrauder, Li Yan, Dan Wang, Leonardo Medico, Yuqing Guo, Song Yao, Qianqian Zhu, Biao Liu, Maochun Qin, Matthias W. Beckmann, Peter A. Fasching, Reiner Strick, Candace S. Johnson, Christine B. Ambrosone, Hua Zhao, and Song Liu
|
| 5284-5294 |
|
| Loss of ARID1A expression sensitizes cancer cells to PI3K and AKTinhibition |
|
https://doi.org/10.18632/oncotarget.2092
Eleftherios P. Samartzis, Katrin Gutsche, Konstantin J. Dedes, Daniel Fink, Manuel Stucki, and Patrick Imesch
|
| 5295-5303 |
|
| A FcγRIIIengaging bispecific antibody expands the range of HER2expressing breast tumors eligible to antibody therapy |
|
https://doi.org/10.18632/oncotarget.2093
Marc Turini, Patrick Chames, Pierre Bruhns, Daniel Baty, and Brigitte Kerfelec
|
| 5304-5319 |
|
| Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration |
|
https://doi.org/10.18632/oncotarget.2097
Christina A. von Roemeling, Laura A. Marlow, Derek C. Radisky, Austin Rohl, Hege E. Larsen, Johnny Wei, Heather Sasinowska, Heng Zhu, Richard Drake, Maciek Sasinowski, Han W. Tun, and John A. Copland
|
| 5320-5334 |
|
| Galectin4 expression is associated with reduced lymph node metastasis and modulation of Wnt/βcatenin signalling in pancreatic adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.2104
Mina Maftouh, Ana I. Belo, Amir Avan, Niccola Funel, Godefridus J. Peters, Elisa Giovannetti, and Irma van Die
|
| 5335-5349 |
|
| Macrophages are recruited to hypoxic tumor areas and acquire a ProAngiogenic M2Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin |
|
https://doi.org/10.18632/oncotarget.2110
Chakrapani Tripathi, Brij Nath Tewari, Ranjana Kumari Kanchan, Khemraj Singh Baghel, Naveen Nautiyal, Richa Shrivastava, Harbeer Kaur, Madan Lal Bramha Bhatt, and Smrati Bhadauria
|
| 5350-5368 |
|
| GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the βcatenin signaling |
|
https://doi.org/10.18632/oncotarget.2105
Zongwei Li, Yingying Wang, Haili Wu, Lichao Zhang, Peng Yang, and Zhuoyu Li
|
| 5369-5380 |
|
| Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition |
|
https://doi.org/10.18632/oncotarget.2111
Ilaria Passacantilli, Gabriele Capurso, Livia Archibugi, Sara Calabretta, Sara Caldarola, Fabrizio Loreni, Gianfranco Delle Fave, and Claudio Sette
|
| 5381-5391 |
|
| FOXO1 downregulation contributes to the oncogenic program of primary mediastinal Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.2107
Linka Xie, Olga Ritz, Frank Leithäuser, Hanfeng Guan, Johanna Färbinger, Clarissa D. Weitzer, Franziska Gehringer, Silke Brüderlein, Karlheinz Holzmann, Marion J. Vogel, Peter Möller, Thomas Wirth, and Alexey Ushmorov
|
| 5392-5402 |
|
| Tumor suppressor XAF1 induces apoptosis inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2114
Li Ming Zhu, Dong Mei Shi, Qiang Dai, Xiao Jiao Cheng, Wei Yan Yao, Ping Hu Sun, Yan Fei Ding, Min Min Qiao, Yun Lin Wu, Shi Hu Jiang, and Shui Ping Tu
|
| 5403-5415 |
|
| MiR143 acts as a tumor suppressor by targeting NRAS and enhances temozolomideinduced apoptosis in glioma |
|
https://doi.org/10.18632/oncotarget.2116
Lin Wang, Zhu-mei Shi, Cheng-fei Jiang, Xue Liu, Qiu-dan Chen, Xu Qian, Dong-mei Li, Xin Ge, Xie-feng Wang, Ling-Zhi Liu, Yong-ping You, Ning Liu, and Bing-Hua Jiang
|
| 5416-5427 |
|
| The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism |
|
https://doi.org/10.18632/oncotarget.2117
Anja Pickhard, Michael Siegl, Alexander Baumann, Maximilian Huhn, Markus Wirth, Rudolf Reiter, Martina Rudelius, Guido Piontek, and Gero Brockhoff
|
| 5428-5438 |
|
| Tumorderived exosomes promote tumor progression and Tcell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2118
Shu-biao Ye, Ze-Lei Li, Dong-hua Luo, Bi-jun Huang, Yu-Suan Chen, Xiao-shi Zhang, Jun Cui, Yi-xin Zeng, and Jiang Li
|
| 5439-5452 |
|
| Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth |
|
https://doi.org/10.18632/oncotarget.2113
Ningning Liu, Xiaofen Li, Hongbiao Huang, Chong Zhao, Siyan Liao, Changshan Yang, Shouting Liu, Wenbin Song, Xiaoyu Lu, Xiaoying Lan, Xin Chen, Songgang Yi, Li Xu, Lili Jiang, Canguo Zhao, Xiaoxian Dong, Ping Zhou, Shujue Li, Shunqing Wang, Xianping Shi, Ping Q. Dou, Xuejun Wang, and Jinbao Liu
|
| 5453-5471 |
|
| Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.2121
Barbara Chiavarina, Marie-Julie Nokin, Florence x Florence Durieux, Elettra Bianchi, Andrei x Andrei Turtoi, Olivier Peulen, Paul Peixoto, Philippe Irigaray, Koji Uchida, Dominique Belpomme, Philippe Delvenne, Vincent Castronovo, and Akeila Bellahcène
|
| 5472-5482 |
|
| Hedgehog signaling sensitizes Glioma stem cells to endogenous nanoirradiation |
|
https://doi.org/10.18632/oncotarget.2123
Agnieszka Morgenroth, Andreas T. J. Vogg, Katja Ermert, Boris Zlatopolskiy, and Felix M. Mottaghy
|
| 5483-5493 |
|
| A nucleolinDNMT1 regulatory axis in acute myeloid leukemogenesis |
|
https://doi.org/10.18632/oncotarget.2131
Na Shen, Fei Yan, Jiuxia Pang, Lai-Chu Wu, Aref Al-Kali, Mark R. Litzow, and Shujun Liu
|
| 5494-5509 |
|
| Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis |
|
https://doi.org/10.18632/oncotarget.2132
Marineta Kovacheva, Michael Zepp, Stefan M. Berger, and Martin R. Berger
|
| 5510-5522 |
|
| Sensitization of radioresistant prostate cancer cells with a unique cytolethal distending toxin |
|
https://doi.org/10.18632/oncotarget.2133
Chih-Ho Lai, Chia-Shuo Chang, Hsin-Ho Liu, Yuh-Shyan Tsai, Feng-Ming Hsu, Yung-Luen Yu, Cheng-Kuo Lai, Leah Gandee, Rey-Chen Pong, Heng-Wei Hsu, Lan Yu, Debabrata Saha, and Jer-Tsong Hsieh
|
| 5523-5534 |
|
| Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD |
|
https://doi.org/10.18632/oncotarget.2137
Cen Zhang, Juan Liu, Rui Wu, Yingjian Liang, Meihua Lin, Jia Liu, Chang S. Chan, Wenwei Hu, and Zhaohui Feng
|
| 5535-5546 |
|
| Hepatocyte growth factorlike protein is required for prostate tumor growth in the TRAMP mouse model |
|
https://doi.org/10.18632/oncotarget.2139
Juozas Vasiliauskas, Madison A. Nashu, Peterson Pathrose, Sandra L. Starnes, and Susan E. Waltz
|
| 5547-5558 |
|
| Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway |
|
https://doi.org/10.18632/oncotarget.2140
Harish Potu, Luke F. Peterson, Anupama Pal, Monique Verhaegen, Juxiang Cao, Moshe Talpaz, and Nicholas J. Donato
|
| 5559-5569 |
|
| Small interfering RNA siRNAmediated knockdown of macrophage migration inhibitory factor MIF suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation |
|
https://doi.org/10.18632/oncotarget.2141
Xiao-hui Huang, Wei-hua Jian, Zhao-feng Wu, Jie Zhao, Hua Wang, Wen Li, and Jin-tang Xia
|
| 5570-5580 |
|
| Specific delivery of microRNA93 into HBVreplicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA |
|
https://doi.org/10.18632/oncotarget.2143
Motoko Ohno, Motoyuki Otsuka, Takahiro Kishikawa, Chikako Shibata, Takeshi Yoshikawa, Akemi Takata, Ryosuke Muroyama, Norie Kowatari, Masaya Sato, Naoya Kato, Shun'ichi Kuroda, and Kazuhiko Koike
|
| 5581-5590 |
|
| E3ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2149
Jing Wang, Ying Huang, Zhong Guan, Jia-liang Zhang, Hong-kai Su, Wei Zhang, Cai-feng Yue, Min Yan, Su Guan, and Quentin Qiang Liu
|
| 5591-5601 |
|
| The tumor suppressive role of NUMB isoform 1 in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2136
Junmou Hong, Zhenguo Liu, Hua zhu, Xin Zhang, Yongju Liang, Shiyuan Yao, Fang Wang, Xiaoyun xie, Bo Zhang, Tao Tan, Liwu Fu, Jing Nie, and Chao Cheng
|
| 5602-5614 |
|
| Development of replicationcompetent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter |
|
https://doi.org/10.18632/oncotarget.2151
Ho Kyung Seo, Jeong Bin Seo, Jae-Kook Nam, Kyung-Chae Jeong, Seung-Pil Shin Shin, In-Hoo Kim, Sang Don Lee, and Sang-Jin Lee
|
| 5615-5623 |
|
| Upregulation of microRNA135a3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis |
|
https://doi.org/10.18632/oncotarget.2152
Eun Ah Shin, Eun Jung Sohn, Gunho Won, Jeong-Un Choi, Myongsuk Jeong, Bonglee Kim, Min-Jeong Kim, and Sung-Hoon Kim
|
| 5624-5636 |
|
| Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2154
Kyungsoo Ha, Warren Fiskus, Dong Soon Choi, Srividya Bhaskara, Leandro Cerchietti, Santhana G. T. Devaraj, Bhavin Shah, Sunil Sharma, Jenny C. Chang, Ari M. Melnick, Scott Hiebert, and Kapil N. Bhalla
|
| 5637-5650 |
|
| A novel class I HDAC inhibitor MPT0G030 induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and Ecadherin |
|
https://doi.org/10.18632/oncotarget.2155
Li-Ting Wang, Jing-Ping Liou, Yu-Hsuan Li, Yi-Min Liu, Shiow-Lin Pan, and Che-Ming Teng
|
| 5651-5662 |
|
| TFF1 activates p53 through downregulation of miR504 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.2156
Mohammed Soutto, Zheng Chen, Mohamed A. Saleh, Ahmed Katsha, Shoumin Zhu, Alexander Zaika, Abbes Belkhiri, and Wael El-Rifai
|
| 5663-5673 |
|
| Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX970 |
|
https://doi.org/10.18632/oncotarget.2158
Amy B. Hall, Dave Newsome, Yuxin Wang, Diane M. Boucher, Brenda Eustace, Yong Gu, Brian Hare, Mac A. Johnson, Howard Li, Sean Milton, Cheryl E. Murphy, Darin Takemoto, Crystal Tolman, Mark Wood, Peter Charlton, Jean-Damien Charrier, Brinley Furey, Julian Golec, Philip M. Reaper, and John R. Pollard
|
| 5674-5685 |
|
| Multiple myeloma cellderived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation |
|
https://doi.org/10.18632/oncotarget.2159
Bonnie K. Arendt, Denise K. Walters, Xiaosheng Wu, Renee C. Tschumper, and Diane F. Jelinek
|
| 5686-5699 |
|
| Loss of PPM1A expression enhances invasion and the epithelialtomesenchymal transition in bladder cancer by activating the TGFβ/Smad signaling pathway |
|
https://doi.org/10.18632/oncotarget.2144
Jiang Geng, Jie Fan, Qi Ouyang, Xiaopeng Zhang, Xiaolong Zhang, Juan Yu, Zude Xu, Qianyu Li, Xudong Yao, Xiuping Liu, and Junhua Zheng
|
| 5700-5711 |
|
| FAS/FASL are dysregulated in chordoma and their lossoffunction impairs zebrafish notochord formation |
|
https://doi.org/10.18632/oncotarget.2145
Luca Ferrari, Anna Pistocchi, Laura Libera, Nicola Boari, Pietro Mortini, Gianfranco Bellipanni, Antonio Giordano, Franco Cotelli, and Paola Riva
|
| 5712-5724 |
|
| Regulatory role of miR1423p on the functional hepatic cancer stem cell marker CD133 |
|
https://doi.org/10.18632/oncotarget.2167
Stella Chai, Man Tong, Kai Yu Ng, Pak Shing Kwan, Yuen Piu Chan, Tsun Ming Fung, Terence K. Lee, Nathalie Wong, Dan Xie, Yun-Fei Yuan, Xin-Yuan Guan, and Stephanie Ma
|
| 5725-5735 |
|
| HPrune through GSK3β interaction sustains canonical WNT/βcatenin signaling enhancing cancer progression in NSCLC |
|
https://doi.org/10.18632/oncotarget.2169
Marianeve Carotenuto, Pasqualino De Antonellis, Lucia Liguori, Giovanna Benvenuto, Daniela Magliulo, Alessandro Alonzi, Cecilia Turino, Carmela Attanasio, Valentina Damiani, Anna Maria Bello, Fabiana Vitiello, Rosa Pasquinelli, Luigi Terracciano, Antonella Federico, Alfredo Fusco, Jamie Freeman, Trevor C. Dale, Charles Decraene, Gennaro Chiappetta, Francovito Piantedosi, Cecilia Calabrese, and Massimo Zollo
|
| 5736-5749 |
|
| The ALK inhibitor ASP3026 eradicates NPMALK+ Tcell anaplastic largecell lymphoma in vitro and in a systemic xenograft lymphoma model |
|
https://doi.org/10.18632/oncotarget.2170
Suraj Konnath George, Deeksha Vishwamitra, Roxsan Manshouri, Ping Shi, and Hesham M. Amin
|
| 5750-5763 |
|
| Dissecting DNA repair in adult high grade gliomas for patient stratification in the postgenomic era |
|
https://doi.org/10.18632/oncotarget.2180
Christina Perry, Devika Agarwal, Tarek M. A. Abdel-Fatah, Anbarasu Lourdusamy, Richard Grundy, Dorothee T. Auer, David Walker, Ravi Lakhani, Ian S. Scott, Stephen Chan, Graham Ball, and Srinivasan Madhusudan
|
| 5764-5781 |
|
| Thrombospondin 1 promotes an aggressive phenotype through epithelialtomesenchymal transition in human melanoma |
|
https://doi.org/10.18632/oncotarget.2164
Aparna Jayachandran, Matthew Anaka, Prashanth Prithviraj, Christopher Hudson, Sonja J. McKeown, Pu-Han Lo, Laura J. Vella, Colin R. Goding, Jonathan Cebon, and Andreas Behren
|
| 5782-5797 |
|
| Histone demethylase RBP2 induced by Helicobactor Pylori CagA participates in the malignant transformation of gastric epithelial cells |
|
https://doi.org/10.18632/oncotarget.2185
Xiuming Liang, Jiping Zeng, Lixiang Wang, Li Shen, Shuyan Li, Lin Ma, Xinyu Ci, Jingya Yu, Mutian Jia, Yundong Sun, Zhifang Liu, Shili Liu, Wenjuan Li, Han Yu, Chunyan Chen, and Jihui Jia
|
| 5798-5807 |
|
| Oncogenemediated regulation of p53 ISGylation and functions |
|
https://doi.org/10.18632/oncotarget.2199
Yi-Fu Huang, and Dmitry V. Bulavin
|
| 5808-5818 |
|
| Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patientderived xenografts |
|
https://doi.org/10.18632/oncotarget.2171
Wei Wei, Song Wu, Xiaolin Wang, Chris Kin-Wai Sun, Xiaoyang Yang, Xinrui Yan, Mei-Sze Chua, and Samuel So
|
| 5819-5831 |
|
| HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR96 |
|
https://doi.org/10.18632/oncotarget.2200
Jin Feng, Junbo Yu, Xiaolin Pan, Zengliang Li, Zheng Chen, Wenjie Zhang, Bin Wang, Li Yang, Hao Xu, Guoxin Zhang, and Zekuan Xu
|
| 5832-5844 |
|
| Caspase2 regulates oncogeneinduced senescence |
|
https://doi.org/10.18632/oncotarget.2286
Delphine Gitenay, Hélène Lallet-Daher, and David Bernard
|
| 5845-5847 |
